Doximity, Inc.
Doximity, Inc. (DOCS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
docs · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Doximity, Inc. (DOCS) measures how much investors pay for each dollar of the company's trailing earnings. DOCS's current PE ratio of 19.25x is calculated by dividing its stock price of $20.30 by its TTM earnings per share of $1.06. −55.3% discount vs 5Y avg 43.1x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2019 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 8 fiscal years · Front-end computedMinQ1 · 25%55.2x
MedianQ3 · 75%1229.4x
Max
At 19.25x, DOCS's current P/E is lower than in 0% of its annual fiscal year readings over the past 8 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Doximity, Inc.You DOCS | $3.8B | 19.25x | -49.6% | $1.06 |
 The Cooper Companies, Inc. COO | $13.2B | 37.30x | -2.3% | $1.87 |
 Encompass Health Corporation EHC | $10.1B | 18.84x | -50.7% | $5.63 |
 Exact Sciences Corporation EXAS | $20.0B | N/A | — | -$1.10 |
 Guardant Health, Inc. GH | $16.9B | N/A | — | -$3.32 |
 HealthEquity, Inc. HQY | $7.4B | 34.29x | -10.2% | $2.50 |
 ICON Public Limited Company ICLR | $11.6B | 62.31x | +63.2% | $2.92 |
Industry Average 4 peers with valid PE | — | 38.18x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 22.23x | $1.05 | -54.2% | |
2025-03-31 FY2025 | 48.58x | $1.19 | +42.8% | |
2024-03-31 FY2024 | 34.03x | $0.78 | -38.6% | |
2023-03-31 FY2023 | 55.44x | $0.58 | +0.8% | |
2022-03-31 FY2022 | 55.02x | $0.95 | -70.8% | |
2021-03-31 FY2021 | 188.11x | $0.28 | -41.9% | |
2020-03-31 FY2020 | 323.85x | $0.16 | -73.7% | |
2019-03-31 FY2019 | 1229.44x | $0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Doximity, Inc. (DOCS) measures how much investors pay for each dollar of the company's trailing earnings. DOCS's current PE ratio of 19.25x is calculated by dividing its stock price of $20.30 by its TTM earnings per share of $1.06.
Frequently asked questions
DOCS pe ratio · 6 questionsDOCS's current PE ratio is 19.25x as of 2026-06-08, based on a stock price of $20.30 and TTM EPS of $1.06. Data sourced from Financial Modeling Prep via DOCS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Doximity, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08